Tranexamic acid molecule

Tranexamic acid molecule

C010/3118 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 50.5MB

Downloadable file size: 276.1KB

Price image Pricing

Please login to use the price calculator


Caption: Tranexamic acid molecule. Computer model showing the structure of a molecule of tranexamic acid. This drug, marketed as Cyclokapton, is used to treat haemophilia - a genetic disorder that prevents the proper clotting of blood - and menorrhagia, abnormally heavy menstruation. Tranexamic acid is an antifibrinolytic, which prevents the breakdown of fibrin, a protein that is important in the coagulation of blood. It also inhibits the activation of plasminogen to plasmin, an enzyme that breaks down fibrin.

Release details: Model release not required. Property release not available.

Keywords: 1, antifibrinolytic, bleeding, clotting, cyclokapron, drug, haematological, haematology, haemophilia, healthcare, heavy menstrual flow, heavy periods, hematological, hematology, medical, medicine, menorrhagia, one, pharmaceutic, pharmaceutical, pharmacological, pharmacology, pill, plasminogen, single, space-fill, space-filled, still life, still-life, tablet, tranexamic acid, treatment

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.